Monterey Bio Acquisition Corporation
MTRY · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $366 | $339 | $2,039 | $0 |
| Gross Profit | $0 | -$339 | -$2,039 | -$864 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $1,576 | $864 |
| SG&A Expenses | $366 | $0 | $1,576 | $864 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $339 | -$1,113 | $0 |
| Operating Expenses | $366 | $339 | $463 | $864 |
| Operating Income | -$366 | -$339 | -$463 | -$864 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $258 | $224 | $188 | $524 |
| Pre-Tax Income | -$107 | -$115 | -$275 | -$340 |
| Tax Expense | $44 | $38 | $32 | $81 |
| Net Income | -$151 | -$152 | -$307 | -$420 |
| % Margin | – | – | – | – |
| EPS | -0.031 | -0.031 | -0.063 | -0.03 |
| % Growth | 0.3% | 50.4% | -109% | – |
| EPS Diluted | -0.031 | -0.031 | -0.063 | -0.03 |
| Weighted Avg Shares Out | 4,894 | 4,894 | 4,894 | 14,171 |
| Weighted Avg Shares Out Dil | 4,894 | 4,894 | 4,894 | 14,171 |
| Supplemental Information | – | – | – | – |
| Interest Income | $258 | $224 | $188 | $524 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $122 | $42 | $55 | $27 |
| EBITDA | -$366 | -$339 | -$463 | -$864 |
| % Margin | – | – | – | – |